<< Back to the abstract archive
Post-operative Complications following Reduction Mammaplasty in Relation to Patient Body Mass Index
Jessica Suber, MD, Grace Berry, DO, Philip Janszen DO, Steven Janszen DO
Southern Ohio Medical Center
2024-12-13
Presenter: Jordan Tennenbaum
Affidavit:
This has been submitted to ePlasty journal but not published.
Director Name: Jessica Suber
Author Category: Medical Student
Presentation Category: Clinical
Abstract Category: Breast (Aesthetic and Recon.)
Reduction mammaplasty is a common procedure for patients to achieve a proportionate breast size while reducing chronic neck, back, and shoulder pain. The risks of breast reduction include bleeding, scarring, infection, poor healing, fat necrosis, nipple necrosis, and seroma. This study is designed to show that patients with a body mass index (BMI) of >30.0 kg/m2 are at higher risks for all complications.
This retrospective study analyzed medical records of 236 patients who underwent a breast reduction from January 2015 to February 2022 by a single surgeon at a single institution. Patients were divided into 2 groups; BMI, ≤ 29.9 kg/m2 and ≥ 30.0 kg/m2. This study compares postsurgical complications in relation to patient BMI.
Of 236 total patients, 104 (44%) had complications. Of those, 94 (90.38%) had a BMI ≥ 30.0 kg/m2. Complications included: 24 patients with wound dehiscence, 23 with BMI ≥ 30.0 kg/m2; 9 patients with hematoma, all with BMI ≥ 30.0 kg/m2; 37 patients with superficial wounds, 32 with BMI ≥ 30.0 kg/m2; 39 with seroma, 35 with BMI ≥ 30.0 kg/m2; 25 patients with fat necrosis, 24 with BMI ≥ 30.0 kg/m2; 3 patients with nipple necrosis, all with BMI ≥ 30.0 kg/m2; and 20 patients with infection, 19 with BMI ≥ 30.0 kg/m2.
Based on data and statistics, patients with BMI ≥ 30.0 kg/m2 were 4.86 times more likely to have postsurgical complications compared with lower BMI. Obesity isn't a complete contraindication for breast reduction but should warrant communication about associated increased risk factors.
